Basecamp Research Raises $140M to Advance AI-Designed In Vivo Cell Therapies - bioinformant.com/basecamp-re… @Basecamp_Res

Cellares and Seoul National University Hospital Launch Proof-of-Concept for Automated Manufacturing of Gene-Modified HSPC Therapy on the Cell Shuttle® Platform - bioinformant.com/cellares-an… @snuh_official

Made Scientific Expands U.S. GMP Cell Therapy Network with 85,000 Sq. Ft. Pennsylvania Acquisition — Operational on Day One - bioinformant.com/made-scient…

$600M in VC Funding. $1B Milestone Deals. The Exosome Market Is Accelerating. - bioinformant.com/600m-in-vc-… @biotechne @EvOx_Ltd @Capricor @mdxhealth @thermofisher @exocobio @BenevSkincare @codiakbio

Designer Exosomes: How Engineered Vesicles Are Transforming Drug Delivery in 2027 - bioinformant.com/designer-ex… @AnjariumBio @ArunA_Bio @AegleRxCorp @Capricor @codiakbio @EvOx_Ltd @OasisBiotech @riontx

How Human iPSCs are Revolutionizing Drug Discovery in 2027 - bioinformant.com/ipsc-drug-d… @NcardiaStemCell @CellDynamics @bitbio @nexelbio @Evotec

Flip Mycoplasma delivers performance comparable with the best PCR tests in a ready to use format with results in just 12 min & a 3 step workflow, making easier to check your cultures before investing time in the next experiment. Get a free sample kit flip-dx.com/mycoplasma #Ad

I Peace Selected as a TOP 10 Awardee for the “Top 10 Longevity Breakthrough Awards 2026” - bioinformant.com/i-peace-top… @IPeaceInc_E

16 CAR-T Therapies and Counting: How the CAR-T Market Is Evolving and The Companies Leading the Charge -bioinformant.com/globally-ap… @Novartis @GileadSciences @bmsnews @LegendBiotech @JanssenUS @CARsgen_Ther @IASOBiosciences @ActImmuno @Immuneel_

Rose BioSolutions Debuts as Latest CGT CDMO Following GI Partners’ Acquisition of Charles River Businesses - bioinformant.com/rose-biosol…

Aspen Neuroscience Advances Sasineprocel, an Autologous iPSC-Based Therapy for Parkinson’s Disease, Toward Phase 3 - bioinformant.com/aspen-neuro… @AspenNeuro

Anja Health Makes Cord Blood, Cord Tissue and Placenta Banking an Employee Benefit and Invites Other Employers to Join In - bioinformant.com/anja-health… @anjahealth @vitalant

Cord Blood Industry Consolidation Escalates in 2026 - bioinformant.com/cord-blood-… @cordblood @cryobank @GenerateLifeSci @NateraGenetics @ViaCord @PerkinElmer @humanlongevity @Lifebankusa @bmsnews @CryoCell @bcumexico @dentcell @cryocord @PBKM_FamiCord @celularity @AlphaCord

MUSE Cells Now Available at Longevity Medical Institute® - bioinformant.com/muse-cells-… As part of its Regenerative Neurology Program, @Longevity_Cabo is making MUSE cell therapy available to select patients, using cells produced in-house at the Institute’s biotech laboratory.

Five Acquisitions, $600M in VC, and a $1B Milestone: Exosome Dealmaking in 2026 - bioinformant.com/exosome-dea… @mdxhealth @NexTelMedical @exocobio

Cryopraxis, BioNK and Radboudumc Partner to Transfer Cord Blood-Derived NK Cell Technology to Brazil - bioinformant.com/cryopraxis-… @cryopraxis @radboudumc

Greenstone Biosciences Wins Breakthrough T1D Grant to Model Diabetes Using Patient-Derived iPSCs - bioinformant.com/greenstone-… @GreenstoneBio @BreakthroughT1D

New Book “The Language of Healing” Tackles the Patient Education Gap in Regenerative Medicine - bioinformant.com/new-book-th… @Longevity_Cabo

IPS HEART’s iPSC-Derived Cell Therapy, ISX9-CPC, Secures 8th FDA Regulatory Milestone - bioinformant.com/ips-heart-s…

Cell Therapy CDMO Cellipont Bioservices Celebrates Major Manufacturing Milestone: Releases 100th GMP Batch - bioinformant.com/cellipont-b… @cellipont